Keywords: α-گالاکتوسیلسرامید; Cervicovaginal explant; Mucosal immunology; Sexually transmitted infections; Tissue culture; Resident immune cells; CVEx; Cervicovaginal explant; STI; Sexually transmitted infections; MAIT; Mucosal-associated invariant T cells; TRM; Resident memory T cell
مقالات ISI α-گالاکتوسیلسرامید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α-گالاکتوسیلسرامید; Liver; Immunity; Tolerance; Autoimmunity; Antigen presentation; Innate lymphocytes; AIH; autoimmune hepatitis; ALD; autoimmune liver disease; APC; antigen-presenting cell; CTLA-4; cytotoxic T cell antigen-4; DC; dendritic cell; α-GC; α-galactosylceramid
Keywords: α-گالاکتوسیلسرامید; ABCA12; ATP-binding cassette transporter A12; α-GalCer; α-galactosylceramide; AMPK; AMP-activated protein kinase; BMP; bis-monoacylglycero-phosphate; CBE; conduritol B epoxide; CerS; ceramide synthase; CERT; ceramide transport protein; ChlGlc; cholester
Fas/FasL interaction mediates imbalanced cytokine/cytotoxicity responses of iNKT cells against Jurkat cells
Keywords: α-گالاکتوسیلسرامید; iNKT; invariant natural killer T; FasL; Fas ligand; α-GalCer; α-galactosylceramide; APC; antigen presenting cells; CD1d level; Malignant T cell lines; Impaired cytokine production; Intensive cytotoxicity; iNKT cell responses;
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; Natural killer T cells; Nanoparticles; Melanoma; Toll-like receptor ligands;
Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells
Keywords: α-گالاکتوسیلسرامید; Chronic lymphocytic leukemia; Invariant natural killer T cells; CD1d; Retinoic acid; Cytotoxicity; α-GalCer; α-Galactosylceramide; APC; antigen-presenting cell; ATRA; all-trans retinoic acid; CLL; chronic lymphocytic leukemia; DC; dendritic cell; DMSO;
NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway
Keywords: α-گالاکتوسیلسرامید; LPG; lipophosphoglycan; DC; dendritic cells; TCR; T-cell receptor; α-GalCer; α-galactosylceramide; PAMPs; pathogen associated molecular patterns; BMDC; bone marrow-derived dendritic cells; NKT; Leishmania mexicana; LPG; TLR2; Cytokines; Dendritic cells;
Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells
Keywords: α-گالاکتوسیلسرامید; iNKT; invariant Natural Killer T cells; mAb; monoclonal antibody; APCs; antigen-presenting cells; α-GalCer; α-galactosylceramide; ZER; zerumbone; MTTP; microsomal triglyceride transfer protein; AgPP; antigen presentation pathway; MTT; 3-(4,5-dimethylthi
Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation
Keywords: α-گالاکتوسیلسرامید; α-GalCer; α-Galactosylceramide; BSA; bovine serum albumin; CFA; colonisation factor antigen; Con A; concanavalin A; E. coli; Escherichia coli; DMSO; dimethyl sulfoxide; ETEC; enterotoxigenic Escherichia coli; FITC; fluorescein isothiocyanate; HRP; horse
Synthesis of a glucosylated α-S-galactosylceramide as potential immunostimulant
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; KRN7000; Thioglycoside; Immunostimulant;
Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy
Keywords: α-گالاکتوسیلسرامید; aAPC; artificial antigen-presenting cells; αGalCer; α-galactosylceramide; ACT; adoptive cell transfer; ADCC; antibody-dependent cell-mediated cytotoxicity; ALL; Acute Lymphoblastic Leukemia; AML; acute lymphoid leukemia; CAR; chimeric antigen receptor;
NKT-cell glycolipid agonist as adjuvant in synthetic vaccine
Keywords: α-گالاکتوسیلسرامید; Adjuvant; NKT cell; α-galactosylceramide; CD1d; Conjugation;
CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors
Keywords: α-گالاکتوسیلسرامید; iNKT; Autoreactivity; TCR; CDR3β; aAPC; artificial antigen-presenting cells; α-GalCer; α-galactosylceramide; β-GlcCer; β-glucopyranosylceramide; CDR; complementarity-determining region; eLPA; C16-alkanyl-lysophosphatidic acid; iNKT; invariant natural
In vivo and in vitro analyses of α-galactosylceramide uptake by conventional dendritic cell subsets using its fluorescence-labeled derivative
Keywords: α-گالاکتوسیلسرامید; αGC; α-galactosylceramide; cDCs; conventional dendritic cells; Cy5-αGC; Cy5-conjugated αGC; iNKT; cells invariant natural killer T cells; α-Galactosylceramide; Dendritic cells; IFN-γ; iNKT cells; Subsets;
The transcriptional programs of iNKT cells
Keywords: α-گالاکتوسیلسرامید; α-GalCer; α-galactosylceramide; BTB-POZ-ZF; broad complex, tramtrack, bric-a-brac or poxvirus and zinc finger; CCR2; C-C chemokine receptor type 2; CCR10; C-C chemokine receptor type 10; ChIP-seq; chromatin immunoprecipitation with deep sequencing
Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8+ T-cell responses and prevent tumour progression
Keywords: α-گالاکتوسیلسرامید; Cancer vaccines; Melanoma; Liposomes; Long peptides; Invariant natural killer T cells; α-Galactosylceramide;
Research ArticleRapid activation and hepatic recruitment of innate-like regulatory B cells after invariant NKT cell stimulation in mice
Keywords: α-گالاکتوسیلسرامید; NKT; natural killer T cell; α-GalCer; α-galactosylceramide; MZ-like B cell; marginal zone like B cell; ALT; alanine transaminase; Breg; regulatory B cell; TGF-β; transforming growth factor β; α-galactosylceramide; Cytokine; CD20; IL-10; Co-stimulator
All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; CD1d; CD38; Retinoic acid; NKT cell; IL-4 production; IFNγ production; APC; antigen-presenting cell; αGalCer; α-galactosylceramide; DC; dendritic cell; LAMP1; lysosomal-associated membrane protein 1; NKT; natural killer T cell;
Design and evaluation of surface and adjuvant modified PLGA microspheres for uptake by dendritic cells to improve vaccine responses
Keywords: α-گالاکتوسیلسرامید; PLGA; Human primary dendritic cells; Polyethyleneimine; Monophosphoryl lipid A; Polyinosinic-polycytidilic acid; α-galactosylceramide;
Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system
Keywords: α-گالاکتوسیلسرامید; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; BTN3A; butyrophilin 3A (CD277); DC; dendritic cell; DMAPP; dimethylallyl pyrophosphate; α-GC; α-galactosylceramide; HMB-PP; (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate; ICOS; inducible
Research ArticleA bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitis
Keywords: α-گالاکتوسیلسرامید; α-GalCer; α-galactosylceramide; ALT; alanine aminotransferase; AST; aspartate aminotransferase; ConA; concanavalin A; iNKT cell; invariant natural killer T cell; LR; leptin receptor; MAPK; mitogen-activated protein kinase; mAlb; mouse serum albumin spec
CD1d expressed in mast cell surface enhances IgE production in B cells by up-regulating CD40L expression and mediator release in allergic asthma in mice
Keywords: α-گالاکتوسیلسرامید; α-Gal; α-galactosylceramide; APC; antigen presenting cells; BAL; Bronchoalveolar lavage; BMMCs; Bone marrow-derived mast cells; CCL2; Chemokine ligand 2; CCR2; Chemokine receptor 2; CD1dâ/â; CD1d KO; LTs; leukotrienes; MMPs; Matrix metalloproteinase
CD1d favors MHC neighborhood, GM1 ganglioside proximity and low detergent sensitive membrane regions on the surface of B lymphocytes
Keywords: α-گالاکتوسیلسرامید; MHC; major histocompatibility complex; CD1; cluster of differentiation 1; NKT cells; natural killer T cells; iNKT; invariant natural killer T cells; β2m; β2-microglobulin; MβCD; methyl-β-cyclodextrin; FRET; fluorescence resonance energy transfer; NCS;
Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; Natural killer T cell; Multiple myeloma; Tumor vaccine;
Natural killer and natural killer T cells in liver fibrosis
Keywords: α-گالاکتوسیلسرامید; α-GalCer; α-galactosylceramide; DC; Dendritic cell; DDC; 3,5-diethoxycarbonyl-1,4-dihydrocollidine; HSC; hepatic stellate cell; iNKT; invariant NKT; KIR; killer Ig-like receptor; MCD diet; methionine choline-deficient diet; NAFLD; nonalcoholic fatty liv
Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model
Keywords: α-گالاکتوسیلسرامید; Tregs; T regulatory cells; iNKT cells; invariant natural killer T cells; α-GalCer; α-galactosylceramide; IFN-γ; interferon γ; IL-4; interleukin 4; APC; antigen-presenting cells; BL/6 mice; C57BL/6 mice; DEREG mice; depletion of the regulatory Treg mic
Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice
Keywords: α-گالاکتوسیلسرامید; AAR; area at risk; αGC; α-galactosylceramide; IFN-γ; interferon-γ; IL; interleukin; iNKT; invariant natural killer T; I/R; ischemia/reperfusion; IS; infarct size; LV; left ventricle; MI; myocardial infarction; MNCs; mononuclear cells; MPO; myeloperoxi
Mechanisms of allergy and clinical immunologyT-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death
Keywords: α-گالاکتوسیلسرامید; TIM-1; natural killer T; apoptosis; asthma; AHR; Airway hyperreactivity; BAL; Bronchoalveolar lavage; α-GalCer; α-Galactosylceramide; NKT; Natural killer T; OVA; Ovalbumin; PtdSer; Phosphatidylserine; RSV; Respiratory syncytial virus; TIM; T-cell immuno
Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines
Keywords: α-گالاکتوسیلسرامید; PLGA; Vaccine; Adjuvant; MPLA; Poly(I:C); α-Galactosylceramide;
A flexible approach to construct three contiguous chiral centers of sphingolipids, and asymmetric synthesis of d-ribo-phytosphingosine and its derivatives
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; Ceramide; Sphingolipid; Asymmetric synthesis; Phytosphingosine;
Ex-vivo α-Galactosylceramide activation of NKT cells in humans and macaques
Keywords: α-گالاکتوسیلسرامید; NKT cells; Macaques; α-Galactosylceramide; Optimization of ex-vivo activation; SIV infection;
Dysregulation of CD1d-Restricted Type II Natural Killer T Cells Leads to Spontaneous Development of Colitis in Mice
Keywords: α-گالاکتوسیلسرامید; IBD; Crohn's Disease; Immune Regulation; T-Cell Development; α-GalCer; α-galactosylceramide; DSS; dextran sulfate sodium; HBSS; Hank's balanced salt solution; IFN; interferon; IL; interleukin; NK; natural killer; TCR; T-cell receptor;
Synthesis of α-S-galactosylceramides with a truncated sphingoid chain
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; Thioglycoside; Glycosyl thiol; Immunostimulant;
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
Keywords: α-گالاکتوسیلسرامید; αGalCer; α-galactosylceramide; DC; dendritic cell; HNSCC; head and neck squamous cell carcinoma; SD; stable disease; PR; partial response; Human; NKT cell; Tumor immunity;
Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin
Keywords: α-گالاکتوسیلسرامید; Food allergy; invariant natural killer T cells; sphingolipids; αGal; α-Galactosylceramide; APC; Antigen-presenting cell; CFSE; 5,6-Carboxyfluoresceindiacetate succinimidyl ester; CHOP; The Children's Hospital of Philadelphia; CM; Complete medium; DMSO
Facile synthesis of biotin-labelled α-galactosylceramide as antigen for invariant natural killer T cells
Keywords: α-گالاکتوسیلسرامید; Natural killer T cells; α-Galactosylceramide; Biotin; CD1d;
β-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus
Keywords: α-گالاکتوسیلسرامید; NK; natural killer; dsDNA; double stranded DNA; α-GalCer; α-galactosylceramide; β-GalCer; β-galactosylceramide; Innate immunity; NKT cells; T cells; Systemic lupus erythematosus;
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)
Keywords: α-گالاکتوسیلسرامید; α-GC; α-galactosylceramide; ADCC; antibody-dependent cell-mediated cytotoxicity; DC; dendritic cells; huHMFG-1; humanized human milk fat globulin-1; iNKT; invariant natural killer T-cells; LPS; lipopolysaccharide; mAb; monoclonal antibodies; NK cells; n
Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice
Keywords: α-گالاکتوسیلسرامید; DC; dendritic cell; APC; antigen-presenting cells; CTL; cytotoxic T lymphocytes; α-GalCer; α-galactosylceramide; MNC; mononuclear cells; TB; tumor bearing; α-Galactosylceramide; CD1d; Liver dendritic cells; Antitumor immunity;
Changes in natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma
Keywords: α-گالاکتوسیلسرامید; CH; chronic hepatitis; α-GalCer; α-galactosylceramide; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IFN; interferon; IL; interleukin; NKT; natural killer T; NKT cell; HCV-related disease; Therapy; Cytokine; α-Galactosylceramide;
CD1 assembly and the formation of CD1-antigen complexes
Keywords: α-گالاکتوسیلسرامید; αGalCer; α-galactosylceramide; β2m; beta-2 microglobulin; AP; adaptor protein; DC; dendritic cell; DDM; didehydroxymycobactin; ER; endoplasmic reticulum; GMM; glucose monomycolate; Ii; invariant chain; LAM; lipoarabinomannan; MTP; microsomal triglyceri
Natural killer T cells: rapid responders controlling immunity and disease
Keywords: α-گالاکتوسیلسرامید; Cytokines; Interleukin-4; α-Galactosylceramide; CD1d; Immune response;
ICOS costimulates invariant NKT cell activation
Keywords: α-گالاکتوسیلسرامید; NKT cells; α-Galactosylceramide; ICOS; CD28; IFN-γ; IL-4; Cytotoxicity; Anti-tumor effect;
Cytokine production and migration of in vitro-expanded NK1.1â invariant Vα14 natural killer T (Vα14i NKT) cells using α-galactosylceramide and IL-2
Keywords: α-گالاکتوسیلسرامید; CD1d; α-Galactosylceramide; NKT cell; Cytokine;
Neutralization of tumor necrosis factor abrogates hepatic failure induced by α-galactosylceramide without attenuating its antitumor effect in aged mice
Keywords: α-گالاکتوسیلسرامید; α-Galactosylceramide; TNF; Fas-ligand; NK1.1 Ag+ T cells; Hepatotoxicity; Antitumor immunity; NKT cells; NK1.1Ag+ T cells; α-GalCer; α-galactosylceramide; MNC; mononuclear cells; Fas-L; Fas-ligand; TNFR; TNF receptor; ALT; alanine aminotransferase; LDH